ArticleOncoTargets and therapy2018

Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer.

Osmond J D'Cruz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.